Clinical Trials Browser

Phase 1/2 × Dactinomycin × Clear all

NCT04625907 2024-05-23

FaR-RMS

Phase 1/2 Recruiting

Rhabdomyosarcoma

NCT01531244 2014-07-18

Isolated Limb Infusion Chemotherapy With Targeted Gene Therapy for Advanced, Unresectable Extremity Melanoma

Phase 1/2 Withdrawn

Melanoma